LIQT:NASDAQLiqTech International, Inc. Analysis
Data as of 2026-05-27 - not real-time
$1.26
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: LIQT is trading well below its 20‑day, 50‑day and 200‑day simple moving averages, with the RSI deep in oversold territory and a bearish MACD crossover. Volume is on an upward trend, but the 30‑day volatility remains extremely high, indicating a choppy price environment.
Fundamental outlook: The company continues to post sizable losses, negative cash flow and a debt‑to‑equity ratio that signals heavy leverage. Nonetheless, a record order for ceramic membrane systems in Australia provides a tangible catalyst, and the consensus analyst rating is a strong buy with a target price that implies a multi‑hundred percent upside. The balance sheet weakness and cash burn temper optimism, but the market sentiment reflected in the “Extreme Greed” index suggests investors are pricing in a potential turnaround.
Fundamental outlook: The company continues to post sizable losses, negative cash flow and a debt‑to‑equity ratio that signals heavy leverage. Nonetheless, a record order for ceramic membrane systems in Australia provides a tangible catalyst, and the consensus analyst rating is a strong buy with a target price that implies a multi‑hundred percent upside. The balance sheet weakness and cash burn temper optimism, but the market sentiment reflected in the “Extreme Greed” index suggests investors are pricing in a potential turnaround.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold technical indicators suggest a near‑term price rebound
- Increasing trading volume supports potential short‑term momentum
- Record order provides immediate revenue visibility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued earnings losses and high leverage constrain upside
- Cash burn may require additional financing
- Potential pipeline expansion from new contracts
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Fundamental turnaround dependent on sustained order flow
- Industry trends toward clean‑technology filtration are favorable
- Balance‑sheet remediation needed to reduce financial risk
Key Metrics & Analysis
Financial Health
Revenue Growth-10.40%
Profit Margin-55.45%
P/E Ratio-1.8
ROE-79.31%
ROA-18.26%
Debt/Equity170.75
P/B Ratio1.6
Op. Cash Flow$-6752461
Free Cash Flow$-3636122
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI23.5
Support$1.22
Resistance$2.50
MA 20$2.04
MA 50$1.92
MA 200$1.99
MACDBearish
VolumeIncreasing
Fear & Greed Index92.34
Valuation
Target Price$4.40
Upside/Downside250.60%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.66
Volatility142.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.